[{"Assets_0_Q1_USD":42333000000.0,"CommonStockSharesConverted_0_Q1_shares":347860891.0,"CommonStockSharesOutstanding_0_Q1_shares":347860891.0,"EarningsPerShareBasic_1_Q1_USD":1.8,"EarningsPerShareDiluted_1_Q1_USD":1.79,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":954000000.0,"NetIncomeLossConverted_1_Q1_USD":629000000.0,"RevenuesConverted_1_Q1_USD":2076000000.0,"StockholdersEquity_0_Q1_USD":3893000000.0,"StockholdersEquityConverted_0_Q1_USD":3994000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":350500000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":349800000.0,"Ticker":"BHC","CIK":"885590","name":"VALEANT PHARMACEUTICALS INTERNATIONAL, INC.","OfficialName":"Bausch Health Companies Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7962573421.0","Country":"Canada","Sector":"nan","Industry":"nan","Market":"NYSE","SP500":"nan","filed":"20170509"}]